A serum factor was demonstrated in normal individuals which ( 1 ) enhances the incorporation of L-[3H]fucose into cultured human skin fibroblasts, (2) is nondialyzable, (3) is heat labile at 50°, (4) is present in the uoneuglobulin fraction, and (5) appears to be deficient in serum from patients with cystic fibrosis. The specific activity of L-[3H]fucose incorporated into skin fibroblasts from normal individuals in the presence of serum from 12 control subjects was 3,337 * 168 cpm/mg protein in contrast to 2,294 4 172, the activity obtained either in the presence of serum from 10 age-matched patients with cystic fibrosis or in the absence of serum. These differences were significant at P < 0.001. In comparison, no significant difference was detected in the amount of L-[3H]fucose incorporated into skin fibroblasts derived from normal individuals and patients with cystic fibrosis. The plasma membrane of cultured skin fibroblasts derived from patien& with cystic fibrosis appears to be grossly unaltered in its protein and L-fucose labeling pattern.
Speculation
The plasma membrane of cultured skin fibroblasts derived from patients with cystic fibrosis is not altered. The abnormalities at the plasma membrane level as previously reported may be the consequence of the interaction between the factor described here and plasma membranes.
Cystic fibrosis is an autosomal recessive disorder in which the basic defect is unknown (8) . Abnormalities in cellular transport mechanisms at the plasma membrane level have been proposed to explain elevated ion concentrations in various secretions of patients with cystic fibrosis. Studies from several laboratories have shown that saliva, sweat, and plasma from patients with cystic fibrosis can alter the movement of various molecules across plasma membrane (6, 11, 13) . In addition, a serum factor from patients with cystic fibrosis has been reported to cause disorganization of the ciliary beat of explants of rabbit trachea (16) and cessation of the ciliary beat of oysters (5) and mussels (3) . Since the ciliary movement has been suggested to be controlled by the cell membrane (15) , the anticiliary effect of serum factor found in patients with cystic fibrosis could be the consequence of the interaction between the factor and plasma membranes. Fitzpatrick et al. (10) have shown that membranes of red blood cells obtained from patients with cystic fibrosis frequently demonstrate an alteration in electrophoretic patterns on polyacrylamide gels. A similar alteration of electrophoretic patterns occurred when membranes isolated from normal red blood cells were incubated with CaCI,. These observations strongly suggest the involvement of plasma membranes in cystic fibrosis. The possible alteration in plasma membranes could represent either a primary defect o r a secondary manifestation resulting from the interaction between the ration into culiured skin fibrdblasts from normal-individuals and patients with cystic fibrosis was studied. This approach was utilized as previous studies have shown that much of the L-fucose taken up by several types of mammalian cells was directly incorporated into the plasma membrane fraction (1, 4). Similar protein patterns and L-fucose labeling patterns were obtained with plasma membranes prepared from cultured skin fibroblasts from normal individuals and patients with cvstic fibrosis. A serum factor was demonstrated in normal individuals which enhances the incorporation of L-[3H]fucose into cultured skin fibroblasts and appears to be deficient in serum from patients with cystic fibrosis. In contrast, there is no significant difference in the amount of L-[3H]fucose incorporated into skin fibroblasts derived from normal individuals and patients with cystic fibrosis.
MATERIALS A N D METHODS
CELL CULTURES AND SERA Skin fibroblasts derived from normal individuals and patients with cystic fibrosis were grown in minimal essential medium supplemented with 15% fetal calf serum, penicillin, streptomycin, and fungizone as described previously (14) . Serum samples obtained from 10 children with cystic fibrosis, 2 obligate heterozygotes, and 12 age-matched control subjects were dialyzed against 0.01 M sodium phosphzte-buffered saline, pH 7.0, for 16 hr and stored at -20°. Skin biopsies and serum samples were obtained with informed consent under the guidelines of the Department of Health, Education and Welfare and with the approval of the Human Ethics and Research Committee of The Children's Memorial Hospital.
LABELING, PREPARATION, AND ELECTROPHORESIS O F PLASMA MEMBRANES
The culture medium was replaced with fresh medium containing 0.5 pCi/ml L-[3H]fucose (specific activity: 3.18 Ci/mmol) (18) on the third day after subculture. After incubation for 16 hr, the cells were harvested by scraping with a rubber policeman. The plasma membrane fraction was prepared by using sucrose and Ficoll gradients according to the method of Warren et al. (17) and examined under a phase-contrast microscope. The purified membrane fraction was then solubilized and separated by electrophoresis on a sodium dodecyl sulfate-polyacrylamide gel as described by Fairbanks et al. (9) except that 0.5 M urea was added. After electrophoresis, the gel was sliced and incubated at 50° for 2 hr with 0.5 ml N C S solubilizer H 2 0 (9: 1) (18). The radioactivity was determined in a liquid scintillation counter (19) with 3H efficiency of 45%. The gels were stained for protein with Coomassie blue.
ASSAY O F L-[3H]FUCOSE lNCORPORATlON
-"factors" and plasma membranes.
At confluency, fibroblasts were removed from flasks by scraping In order to evaluate the potential abnormalities of plasma with a rubber policeman. After washing twice with 0.15 M NaC1, 0, and precipitated with 5% trichloroacetic acid. The precipitate was then dissolved in 2 N NaOH and the radioactivity was determined as described above. As shown in Table I , the specific activity of L-[3H]fucose incorporated into skin fibroblasts from normal individuals in the Dresence of serum from 12 control subiects was determined to be i,337 168 (mean * S D ) which is significantly higher than the value of 2,294 * 172 obtained in the presence of serum from 10 age-matched patients with cystic fibrosis (P < 0.001). The average value of L-[3H]fucose incorporation with serum from two obligate heterozygotes was similar to that from control subjects. Mixing serum from control subjects and patients with cystic fibrosis yielded an intermediate value of 2, 803 . This observation appears to exclude the possibility that an inhibitor is present in serum from patients wirh cystic fibrosis or an activator is present in serum The points represent the average of experiments with serum samples from three normal individuals and three patients with cystic fibrosis. from control subjects. Results as shown Table I also revealed no significant difference in the amount of L-[3H]fucose incorporated into skin fibroblasts derived from five normal individuals and two patients with cystic fibrosis. The factor was found to be present in the noneuglobulin fraction of control serum which did not precipitate after dialysis against water saturated with C 0 2 at 4O, was inactivated with heating at 50° for 30 min, and was in the 0-30% (w/v) ammonium sulfate fraction of normal serum.
RESULTS

DISCUSSION
These data demonstrate the presence of a serum factor in normal individuals which (1) enhances the incorporation of L-[3H]fucose into cultured human skin fibroblasts, (2) is nondialyzable, (3) is heat labile at 50°, (4) is present in the noneuglobulin fraction, and (5) is absent in serum from patients with cystic fibrosis. This factor is distinguishable from the factor described by Spock et a/. (16) which was found to be associated with the euglobulin fraction of serum and present in the patients with cystic fibrosis and obligate heterozygotes.
As has been shown in Figure 2 , there was a significant amount of L-[3H]fucose incorporated into skin fibroblasts in the absence of serum. This endogenous incorporation could be due to the presence of fetal calf serum in the culture medium for skin fibroblasts since substantial enhancement of L-[3H]fucose incorporation was also observed with fetal calf serum (7) . The intermediate value obtained by mixing equal amounts of serum from control subjects and patients with cystic fibrosis (Table I ) strongly suggests the absence of an inhibitor in serum from patients with cystic fibrosis and an activator in serum from normal individuals. The absence of an inhibitor in serum from patients with cystic fibrosis was also shown in Figure 3 . There was no significant inhibition of L-[3H]fucose incorporation with increasing concentration of serum from patients with cystic fibrosis to a final concentration of 30%. Since the nature of the stimulator of the L-fucose incorporation is, at present, not clear, definite conclusions can only be drawn when the factor is isolated and characterized. The values of L-[3H]fucose incorporation with serum from obligate heterozygotes were found to be within the range of control values. This assay is, at present, unable to determine heterozygotes of cystic fibrosis. Future experiments can be directed towards increasing the sensitivity of the assay by minimizing the amount of L-fucose incorporation in the absence of serum and purifying the factor.
T h e reaction was incubated a t 37' for 3 h. Values were calculated from:
[(incorporation with serum -incorporation without serum)/(incorporation without serum)] x 100% with serum samples from 12 control subjects (0----0) a n d 10 patients with cystic fibrosis (@--@) a n d expressed a s m e a n SD. (3) is heat l a b i l e at 50°, (4) i s p r e s e n t i n the n o n e u g l o b u l i n f r a c t i o n , a n d (5) 
